Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Pharmacokinetic-pharmacodynamic modeling of tolerance to the prolactin-secreting effect of chlorprothixene after different modes of drug administration.

Bagli M, Süverkrüp R, Quadflieg R, Höflich G, Kasper S, Möller HJ, Langer M, Barlage U, Rao ML.

J Pharmacol Exp Ther. 1999 Nov;291(2):547-54.

PMID:
10525070
2.

Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations.

Bagli M, Rao ML, Höflich G, Kasper S, Langer M, Barlage U, Beneke M, Süverkrüp R, Möller HJ.

Arzneimittelforschung. 1996 Mar;46(3):247-50.

PMID:
8901143
3.

Bioequivalence and absolute bioavailability of oblong and coated levomepromazine tablets in CYP2D6 phenotyped subjects.

Bagli M, Höflich G, Rao ML, Langer M, Baumann P, Kolbinger M, Barlage U, Kasper S, Möller HJ.

Int J Clin Pharmacol Ther. 1995 Dec;33(12):646-52.

PMID:
8963481
4.

Pharmacokinetics and bioavailability of benperidol in schizophrenic patients after intravenous and two different kinds of oral application.

Seiler W, Wetzel H, Hillert A, Schöllnhammer G, Langer M, Barlage U, Hiemke C.

Psychopharmacology (Berl). 1994 Dec;116(4):457-63.

PMID:
7701049
5.

Supplemental Content

Loading ...
Support Center